View Item 

Show simple item record

A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma

dc.contributor.authorFreedman, Gary M.en_US
dc.contributor.authorZalupski, Mark M.en_US
dc.contributor.authorSmall, Williamen_US
dc.contributor.authorMulcahy, Mary F.en_US
dc.contributor.authorHoffman, John P.en_US
dc.contributor.authorMcGinn, Cornelius J.en_US
dc.contributor.authorColletti, Lisa M.en_US
dc.contributor.authorWayne, Jeffrey D.en_US
dc.contributor.authorAttaluri, Vikramen_US
dc.contributor.authorKinsella, Timothy J.en_US
dc.contributor.authorPhilip, Philip A.en_US
dc.contributor.authorTalamonti, Mark S.en_US
dc.date.accessioned2006-09-08T19:13:44Z
dc.date.available2006-09-08T19:13:44Z
dc.date.issued2006-02en_US
dc.identifier.citationTalamonti, Mark S.; Small, William; Mulcahy, Mary F.; Wayne, Jeffrey D.; Attaluri, Vikram; Colletti, Lisa M.; Zalupski, Mark M.; Hoffman, John P.; Freedman, Gary M.; Kinsella, Timothy J.; Philip, Philip A.; McGinn, Cornelius J.; (2006). "A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma." Annals of Surgical Oncology 13(2): 150-158. <http://hdl.handle.net/2027.42/41411>en_US
dc.identifier.issn1534-4681en_US
dc.identifier.issn1068-9265en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/41411
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16418882&dopt=citationen_US
dc.description.abstractWe report the results of a multi-institutional phase II trial that used preoperative full-dose gemcitabine and radiotherapy for patients with potentially resectable pancreatic carcinoma.en_US
dc.format.extent304717 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlag; The Society of Surgical Oncology, Inc.en_US
dc.subject.otherSurgeryen_US
dc.subject.otherMedicine & Public Healthen_US
dc.subject.otherOncologyen_US
dc.subject.otherNeoadjuvant Therapyen_US
dc.subject.otherSurgical Oncologyen_US
dc.subject.otherPancreas Canceren_US
dc.subject.otherGemcitabine and Radiotherapyen_US
dc.subject.otherPancreas Surgeryen_US
dc.titleA Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinomaen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelSurgery and Anesthesiologyen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Gastrointestinal Surgery, University of Michigan Health System, 2922 G Taubman-0331, 1500 E. Medical Center Drive, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationumHematology Oncology, University of Michigan Health System, 1500 E. Medical Center Drive, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationotherDepartment of Radiation Oncology, University of South Maine, 22 Bramhall Street, Portland, Maine, 04102en_US
dc.contributor.affiliationotherDivision of Surgical Oncology, Feinberg School of Medicine, Northwestern University, 201 E. Huron, Galter 10-105, Chicago, Illinois, 60611en_US
dc.contributor.affiliationotherDivision of Radiation Oncology, Feinberg School of Medicine, Northwestern University, 251 E. Huron, LC-178, Chicago, Illinois, 60611en_US
dc.contributor.affiliationotherDivision of Surgical Oncology, Feinberg School of Medicine, Northwestern University, 201 E. Huron, Galter 10-105, Chicago, Illinois, 60611en_US
dc.contributor.affiliationotherDivision of Surgical Oncology, Feinberg School of Medicine, Northwestern University, 201 E. Huron, Galter 10-105, Chicago, Illinois, 60611en_US
dc.contributor.affiliationotherDepartment of Radiation Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, Pennsylvania, 19111en_US
dc.contributor.affiliationotherDepartment of Radiation Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, Pennsylvania, 19111en_US
dc.contributor.affiliationotherDivision of Hematology Oncology, Wayne State University, 3990 John R. Street, Detroit, Michigan, 48201-2018en_US
dc.contributor.affiliationotherDepartment of Radiation Oncology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, Ohio, 44106-6068en_US
dc.contributor.affiliationotherDivision of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, 675 N. St. Clair, Galter 21-100, Chicago, Illinois, 60611en_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid16418882en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/41411/1/10434_2006_Article_9435.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1245/ASO.2006.03.039en_US
dc.identifier.sourceAnnals of Surgical Oncologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
10434_2006_Article_9435.pdf
Size:
297.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.